| |
|
|
|
Kazia Therapeutics Limited  
|
|
3.2876 -0.002 (-0%) |
02-19 12:53 |
|
Open: |
3.15 |
Pre close: |
3.29 |
Target:
|
4.67
|
|
High: |
3.29 |
Low: |
3.15 |
Resistance:
|
4.00
4.67
|
|
Volume: |
1,116 |
Market Cap: |
20M |
Support:
|
2.93
2.27
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.27
 |
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
3.33  |
Signal(12,26,9): |
0.17 |
|
MA(100): |
2.84 |
Stochastic Oscillator |
%K(14,3):
|
22.39 |
|
MA(250): |
3.81 |
%D(3): |
24.72 |
|
Average Volume(K) |
3-Month: |
454
|
52-Week |
High:
|
6.68 |
|
10-Days: |
426 |
Low: |
2.04 |
|
RSI |
RSI(14):
|
53.74 |
Change(%): |
-24.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-26.1 |
Shares Out. (M) |
4.84 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-18.2 |
Shares Float (M) |
4.82 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-63.0 |
% Held by Institutions |
4.80 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.190 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.76 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
